OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
03/12/2026
Back to search
Official data from USPTO
TAVEREN THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
04/03/2026
Trademark type
Combined
Nice classes
5, 42
Filing date
05/06/2024
Registration date
06/17/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/17/2025
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
16
Owner location
CZ
Examiner
JANSON, ANDREW KYLE
Law office
L50
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of a stylized tree with three butterflies in the place of leaves next to the wording "TAVEREN THERAPEUTICS".
Holders and representatives
Holders
I. S. (pessoa física)
Representatives
Jason J. Mazur ArentFox Schiff LLP
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical drugs for treatment of oncological diseases; chemical preparations for medical purposes for treatment of oncological diseases; diagnostic substances for medical use; chemical preparations for pharmaceutical purposes for treatment of oncological diseases; adjuvants for medical purposes; diagnostic preparations for medical purposes; pharmaceutical compositions for treatment of oncological diseases; biological preparations for use in cell cultures for medical purposes.
Class 42
Research and development for the pharmaceutical industry; development of pharmaceutical preparations and medicines; medical research in the field of oncology; medical research in the field of neurobiology; chemical analysis; analytical laboratory servicesresearch laboratory analysis services in the field of biochemistry; biochemistry research services; chemistry serviceschemical synthesis; advisory services relating to research and development of pharmaceutical drugs; science and technology servicesscientific research; technological consultancy in the field of treatment of oncological diseases; scientific laboratory services; conducting early evaluations in the field of new pharmaceuticals.
Publications
History of USPTO decisions and trademark events.
26 publications found
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/25/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
02/25/2026
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/05/2026
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/18/2026
FIMP
FINAL DISPOSITION PROCESSED
01/18/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/17/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/11/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/17/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
06/17/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/29/2025
PUBO
PUBLISHED FOR OPPOSITION
04/29/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/23/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/01/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/07/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/07/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/07/2025
RFNT
REFUSAL PROCESSED BY IB
12/29/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/06/2024
RFRR
REFUSAL PROCESSED BY MPU
12/06/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/22/2024
CNRT
NON-FINAL ACTION WRITTEN
11/21/2024
DOCK
ASSIGNED TO EXAMINER
11/19/2024
MAFR
APPLICATION FILING RECEIPT MAILED
09/30/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/30/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/26/2024
Continuous trademark protection
Get notified about every new filing that threatens TAVEREN THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.